ETF: ARK Genomic Revolution ETF (ARKG)

Information as of 2019-07-31

Part of ARKETFTRUS

LEI: 254900EYF7TANB19PE71

Series ID: S000042975

212-426-7040
3 East 28th Street
7th Floor
New York, US-NY 10016

http://ark-funds.com.

Taken from NPORT-P filing for 2020-04-30
Total Assets
784949224.51
Total Liabilities
4363253.70
Net Assets
780585970.81
Refresh

Funds Holding ARKG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"
N-CEN Filings
Period of Report View SEC Link
2019-07-31 View Filing Original SEC Filing
2018-07-31 View Filing Original SEC Filing
N-PORT Filings
Period of Report View SEC Link
2020-04-30 - 2020-07-31 View Filing Original SEC Filing

Elevate your investments